Alto Neuroscience

ANRONYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.114 B

$28.67 +0.70%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$63.2M

Loss-making

Shares outstanding

31,945,516

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#153Corvus PharmaceuticalsCRVS$1.17B
#154InventivaIVA$1.13B
#155Alto NeuroscienceANRO$1.11B
#156Lexicon PharmaceuticalsLXRX$1.10B
#157Jade BiosciencesJBIO$1.08B

Where these numbers come from

Share counts and financials for Alto Neuroscience are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.